TARS Stock Analysis: Buy, Sell, or Hold?
TARS - Tarsus Pharmaceuticals, Inc. Common Stock
$65.44
4.55 (7.47%)
▲
5d:
+1.71%
30d:
+13.99%
90d:
-6.81%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.3/10
Get Alerted When TARS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TARS shows positive signals but monitor for confirmation. Market pricing in 14.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: TARS shows positive signals but monitor for confirmation. Market pricing in 14.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$100.42
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$62.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TARS is currently trading at $65.44, which is considered extended relative to its 30-day fair value range of $59.37 to $63.96. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.8) compared to its historical average (36.2). Remarkably, the market is currently pricing in an annual earnings decline of 14.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TARS is in a downtrend. Immediate support is located at $56.51, while resistance sits at $69.48. The stock is showing strong short-term momentum, up 7.5% recently.
Market Sentiment: TARS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $94.11 (+43.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TARS is in a downtrend. Immediate support is located at $56.51, while resistance sits at $69.48. The stock is showing strong short-term momentum, up 7.5% recently.
Market Sentiment: TARS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $94.11 (+43.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$59.37 -
$63.96
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.5%)
- BULLISH: Trading 43.8% below Wall St target ($94.11)
Trading Range Analysis
30-Day Trading Range
$59.37 -
$63.96
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$56.51
Resistance Level
$69.48
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.83
Wall Street Target
$94.11
(+43.8%)
Revenue Growth (YoY)
106.9%
Profit Margin
-9.0%
Valuation Discount vs History
-14.2% cheaper
PE vs Historical
22.8 vs 36.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.2%
(market-implied from PE analysis)
1-Year Target
$58.90
(-10%)
2-Year Target
$53.01
(-19%)
3-Year Target
$47.71
(-27%)
3-Yr Target (if PE normalizes)
(PE: 23→36)
$75.65
(+16%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.8 to 36.2
Stabilization Target:
$103.77
(+58.6%)
PE Expansion Potential:
+58.6%
Share & Embed Analysis
Last updated: July 03, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TARS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
16
Sells
Net
INSIDERS SELLING
Recent Transactions
Bryan Wahl
SELL
4231 shares
2026-03-19
Dianne C Whitfield
SELL
4174 shares
2026-03-19
Elizabeth Yeu Lin
SELL
390 shares
2026-03-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
Advanced TARS Option Strategies
Professional options setups generated by AI based on today's TARS price and gamma walls.
